{"url":"https://lda.senate.gov/api/v1/filings/529d2ef3-11ac-4c62-be4e-58a01d656bb5/","filing_uuid":"529d2ef3-11ac-4c62-be4e-58a01d656bb5","filing_type":"Q3","filing_type_display":"3rd Quarter - Report","filing_year":2025,"filing_period":"third_quarter","filing_period_display":"3rd Quarter (July 1 - Sep 30)","filing_document_url":"https://lda.senate.gov/filings/public/filing/529d2ef3-11ac-4c62-be4e-58a01d656bb5/print/","filing_document_content_type":"text/html","income":"50000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"Beth Anne Cole","dt_posted":"2025-10-20T13:07:38-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":null,"registrant_address_1":"100 M Street, SE","registrant_address_2":"Suite 750","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20003","registrant":{"id":400534596,"url":"https://lda.senate.gov/api/v1/registrants/400534596/","house_registrant_id":41161,"name":"THORN RUN PARTNERS","description":"Government Affairs Firm","address_1":"100 M Street, SE","address_2":"Suite 750","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20003","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"W. CHRISTOPHER LAMOND","contact_telephone":"+1 202-688-0225","dt_updated":"2026-07-09T09:06:40.882848-04:00"},"client":{"id":192581,"url":"https://lda.senate.gov/api/v1/clients/192581/","client_id":874,"name":"BOEHRINGER INGELHEIM PHARMACEUTICALS, INC.","general_description":"pharmaceutical company","client_government_entity":false,"client_self_select":null,"state":"CT","state_display":"Connecticut","country":"US","country_display":"United States of America","ppb_state":"CT","ppb_state_display":"Connecticut","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2016-04-01"},"lobbying_activities":[{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Policies related to creating incentives for innovation in the life sciences.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":50816,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":"ANDY","middle_name":null,"last_name":"ROSENBERG","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70011,"prefix":null,"prefix_display":null,"first_name":"BEAU","nickname":null,"middle_name":null,"last_name":"SCHUYLER","suffix":null,"suffix_display":null},"covered_position":"Legislative Director: Rep. Tanner; Legislative Director: Rep. McIntyre","new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}